Figure 2.

Metabolic inhibitors disrupt glycan biosynthesis. (A) Schematic of benzyl glycosides acting as metabolic inhibitors to divert glycan biosynthesis onto decoy substrates, ultimately leading to truncated glycans on bacteria. (B) Precedented O-glycoside inhibitors from previous work. (C) Novel S-glycoside analogues of bacterial sugar scaffolds used as putative metabolic inhibitors in this study.